Quick Heal Technologies

NSE: QUICKHEALBSE: 539678
Compare with peers
₹ 138.00▼ 0.51 (−0.37%)28 Oct, 03:29 pm IST
Market cap
₹ 749 Cr.
P/E
196.4x
P/B
1.75x
52-week range
125 – 337
ROE
−2%
ROCE
−5%
Dividend yield
0%
Debt / equity
0
Sector
IT - Software
Industry
Software Products
Listed on
NSE, BSE

About

Quick Heal Technologies Limited is an India-based cybersecurity solutions provider, which is engaged in the business of providing security software products. It caters to both the domestic and international markets. The Company operates through the cyber security platform segment. It offers cybersecurity products to Consumers, Small Businesses, Government Establishments, and Corporate Houses. The Company’s products include Quick Heal Total Security, Quick Heal Internet Security, Quick Heal Antivirus Pro, Quick Heal Total Security for Mac, Quick Heal AntiVirus for Server, Quick Heal Total Security Multi-Device, Quick Heal Total Security for Android, and Quick Heal Mobile Security. The Company provides antivirus solutions, Internet security, and total security packages to protect against viruses, malware, and cyber threats. It also provides Endpoint Protection, Enterprise Mobility Management, Zero Trust Network Access, and Data Privacy Management for enterprises.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Software Products: 58 companies →

Quick Heal Technologies against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)196.4 against a typical 32.6: pricier than most peers (1st = cheapest).52nd of 58
  • Sales growth−21.4% against a typical +16.4% from a year earlier.39th of 46
  • Share price, 3 months−13.4% against a typical −9.3%.32nd of 51
  • Size₹ 749.3 Cr. market value against a typical ₹ 59.8 Cr. (1st = largest).11th of 56

Latest announcements

Exchange filings and their impact on the company.

  • 27 Oct 2026Outcome of Board MeetingMedium impactNeutralPrice −0.4% so far today
    Q2 revenue fell 22% YoY but rebounded 44% QoQ back to EBITDA and PAT positive with Rs 57 cr+ enterprise order book.

    Quick Heal reported Q2 FY27 revenue of Rs 64.9 crore, down 22% from last year but up 44% from Q1, with EBITDA of Rs 2.3 crore and net profit of Rs 5.8 crore versus a loss last quarter. Consumer revenue fell sharply while enterprise held up, and the company disclosed an enterprise order book of over Rs 57 crore and lower receivables of Rs 97.8 crore. The board also appointed Grant Thornton as internal auditor and Shailesh Shinde as Company Secretary.

    Filing

Board meetings

Results dates and other board meetings. Full calendar

Details
27 Oct 2026Financial ResultsTo consider and approve the financial results for the period ended September 30, 2026
30 Jul 2026Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2026
21 May 2026Financial ResultsTo consider and approve the financial results for the period ended March 31, 2026
29 Jan 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
15 Oct 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
7 Aug 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025

Share price

1Y change −57.49%
0 of 1 filing day came with a big price move
Volume (shares)Price (₹)
Close price

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales788280707371655784724945
Expenses677070687074746774717863
Operating Profit11121033−4−8−1090−29−18
OPM %14%14.2%12.6%3.7%4.2%−5.3%−13%−17%11.1%0.6%−60.2%−39.1%
Other Income6475556649414
Interest000000000000
Depreciation333333433444
Profit before tax13131455−2−7−7106−30−7
Tax %3.8%19.7%−3.6%16.2%18.2%−104.8%−50.5%−21.3%23.1%−15%−32.8%−27.9%
Net Profit131014440−3−687−20−5
EPS in Rs2.431.892.620.750.770.02−0.6−1.021.461.22−3.68−0.97

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
−1%
5 Years
−5%
3 Years
−2%
TTM
−7%
Compounded Profit Growth
10 Years
—
5 Years
—
3 Years
—
TTM
−138%
Stock Price CAGR
10 Years
−5%
5 Years
−8%
3 Years
−9%
TTM
—
Return on Equity
10 Years
8%
5 Years
4%
3 Years
1%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
71.48%
−0.31 pts in a year
FIIs
0.46%
−0.7 pts in a year
DIIs
0%
−2.58 pts in a year
Public
28.08%
+3.62 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 196.4xEPS (12 months) ₹ 1.06Median P/E 22.2x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Quick Heal Technologies₹ 138.00₹ 749 Cr.196.4x1.8x−2%—
Tata Consultancy Services₹ 2,528.00₹ 9,14,653 Cr.15.7x7.7x48%18.2%
Infosys₹ 1,154.50₹ 4,68,523 Cr.14.8x4.8x31.2%16.5%
HCL Technologies₹ 1,424.00₹ 3,86,426 Cr.18.8x4.4x—13%
Tech Mahindra₹ 1,789.40₹ 1,75,385 Cr.27.9x5.2x—8.7%
Billionbrains Garage Ventures₹ 181.65₹ 1,13,960 Cr.61.3x13.3x—46.5%

Management

Kailash Sahebrao Katkar
Executive Chairman of the Board, Managing Director
Harish Kumar G S
Chief Executive Officer
Ankit Maheshwari
Chief Financial Officer
Vikram Bharat Dhanani
Compliance Officer
Sanjay Sahebrao Katkar
Joint Managing Director, Executive Director
Sarang Hari Deshpande
Company Secretary

Prices are delayed and for information only. Nothing on this page is investment advice.